Accessibility: Skip TopNav
FORZETTO
FORZETTO trial for z-rostudirsen for individuals with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping
Format
PNG
Source
Dyne Therapeutics, Inc.
Downloads
Original
Large
Medium
Small